We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Renal Care Solution Identifies High- or Low-Risk Patients and Recommends Actions for Treatment and Care

By HospiMedica International staff writers
Posted on 18 Mar 2022

An AI renal solution with deep learning models has the ability to classify, track, and transition renal patients through disease states and provide recommended actions for treatment and care. More...

The AI solution developed by SambaNova Systems (Palo Alto, CA, USA) and DeLorean Artificial Intelligence (New York, NY, USA) could significantly advance renal care and has been chosen by Ascend Clinical (Redwood City, CA, USA) to improve patient care.

The DeLorean AI Medical Renal Model running on SambaNova’s platform ingests both structured and unstructured data from internal sources (Ascend or dialysis centers) and external sources like medical records, lab results, previous claims and procedural data. The AI model predicts if a patient will be high- or low-risk and then recommends the next best action for a healthcare professional. This is the first solution on the market to accurately predict risk, provide next best actions, and empower nursing management to hold caregivers accountable for their quality of care.

The financial implications of the AI model are significant, including decreased operating costs and a better customer experience for patients, resulting in a STAR Rating increase, Quality Bonus Payments (QBP), increased CMS Pay 4 Quality (P4Q) and increased revenue. Most importantly, patients benefit from a better quality of life and an extended lifespan. The DeLorean/SambaNova AI solution is subscription-based, can be hosted in the cloud or on-premises, and is extensible to other areas of the business. Labs can deploy the solution for tracking states like diabetes, heart disease or cancer.

“SambaNova and DeLorean’s medical AI solution is revolutionary — we’re bringing AI to an industry that truly needs it,” said Severence MacLaughlin, Ph.D, CEO and founder at DeLorean Artificial Intelligence. “The solution will provide Ascend customers with value-based care by providing them with precise classifications - faster - and timely treatment recommendations along their patient journey.”

“The DeLorean/SambaNova AI solution provides for improved value-based care with AI and has the ability to significantly improve patient outcomes," said Rodrigo Liang, CEO and co-founder of SambaNova Systems. "We're pleased to work with DeLorean AI and Ascend to showcase how AI technology can truly revolutionize the renal care industry."

“We are committed to providing world-class care to our patients, so our laboratories need the most innovative technology," said Paul F. Beyer, CEO of Ascend. “We’re looking forward to advancing our AI initiatives to provide a higher level of precision and improve our customers’ insights into their own data.”

Related Links:
SambaNova Systems 
DeLorean Artificial Intelligence 
Ascend Clinical 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Measuring Rod
seca 233
New
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.